Patents by Inventor James J. Fort

James J. Fort has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of sleep disturbances
    Patent number: 9155718
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Grant
    Filed: October 1, 2014
    Date of Patent: October 13, 2015
    Assignee: Wyeth LLC
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giamalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Inhibitors of crystallization in a solid dispersion
    Patent number: 9107830
    Abstract: A pharmaceutical composition is disclosed which comprises a solid dispersion of a pharmaceutical compound in a water soluble carrier, such as polyethylene glycol (PEG), and a crystallization inhibitor, such as polyvinylpyrrolidone or hydroxypropylmethylcellulose. The solid dispersion may optionally be encapsulated in hard gelatin capsules, compressed into a tablet, or may be granulated with a pharmaceutically acceptable granulating agent. Also disclosed are methods of making said solid dispersion and methods of treatment employing said solid dispersion.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: August 18, 2015
    Assignee: ABBVIE, INC.
    Inventors: James J. Fort, Steven L. Krill, Devalina Law, Yihong Qiu, Eric A. Schmitt
  • Treatment of Sleep Disturbances
    Publication number: 20150018421
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Application
    Filed: October 1, 2014
    Publication date: January 15, 2015
    Applicant: Wyeth LLC
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giamalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Treatment of sleep disturbances
    Patent number: 8883849
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: November 11, 2014
    Assignee: Wyeth LLC
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giamalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Crystalline Pharmaceutical
    Publication number: 20140303369
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Application
    Filed: June 23, 2014
    Publication date: October 9, 2014
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William R. Porter
  • Crystalline pharmaceutical
    Patent number: 8796451
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: August 5, 2014
    Assignee: AbbVie Inc.
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William Porter
  • Treatment of Sleep Disturbances
    Publication number: 20120308483
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Application
    Filed: August 13, 2012
    Publication date: December 6, 2012
    Applicant: Wyeth LLC
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giawalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Treatment of sleep disturbances
    Patent number: 8263647
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: September 11, 2012
    Assignee: Wyeth LLC
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giamalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Crystalline Pharmaceutical
    Publication number: 20110281900
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Application
    Filed: May 13, 2011
    Publication date: November 17, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William R. Porter
  • Crystalline pharmaceutical
    Patent number: 8058433
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Grant
    Filed: October 2, 2006
    Date of Patent: November 15, 2011
    Assignee: Abbott Laboratories
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William Porter
  • Treatment of sleep disturbances
    Publication number: 20090169584
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Application
    Filed: April 10, 2008
    Publication date: July 2, 2009
    Applicant: Wyeth
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giamalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Solid dispersion pharamaceutical formulations
    Patent number: 7364752
    Abstract: A pharmaceutical composition is disclosed which comprises a solid dispersion of an HIV protease inhibitor in a water soluble carrier, such as PEG, having enhanced bioavailability and improved dissolution properties. The solid dispersion may optionally be encapsulated in hard gelatin capsules, compressed into a tablet, or may be granulated with a pharmaceutically acceptable granulating agent. Also disclosed are methods of making said solid dispersion and methods of treating an HIV infection employing said solid dispersion.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: April 29, 2008
    Assignee: Abbott Laboratories
    Inventors: James J. Fort, Steven L. Krill, Devalina Law, Yihong Qiu, William R. Porter, Eric A. Schmitt
  • Crystalline pharmaceutical
    Patent number: 6864369
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: March 8, 2005
    Assignee: Abbott Laboratories
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William Porter
  • Crystalline pharmaceutical
    Publication number: 20030191313
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Application
    Filed: March 12, 2003
    Publication date: October 9, 2003
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William Porter
  • Crystalline pharmaceutical
    Patent number: 6608198
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: August 19, 2003
    Assignee: Abbott Laboratories
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William Porter
  • Treatment of sleep disturbances
    Publication number: 20020177626
    Abstract: The present invention provides a new composition for treating pain-associated sleep disturbances, especially shortened sleep duration, comprising ibuprofen and diphenhydramine. The composition is further prepared as a bilayer tablet or caplet, or alternatively as a soft gelatin capsule composition, to prevent interaction between the active ingredients.
    Type: Application
    Filed: January 17, 2002
    Publication date: November 28, 2002
    Inventors: Graham D. Cook, Todd S. Koch, David H. Giamalva, Justin Bianco, James J. Fort, Geraldine Doyle, Steven Cooper
  • Formulations comprising lipid-regulating agents
    Patent number: 6465011
    Abstract: The present invention is directed to a solid formulation comprising the lipid-regulating agent dispersed in a hydrophilic, amorphous polymer in which said lipid-regulating agent is present as a meta-stable, amorphous phase.
    Type: Grant
    Filed: May 29, 1999
    Date of Patent: October 15, 2002
    Assignee: Abbott Laboratories
    Inventors: Devalina Law, Steven L. Krill, Eric A. Schmitt, James J. Fort
  • Crystalline pharmaceutical
    Publication number: 20010051721
    Abstract: New crystalline forms of lopinavir are disclosed.
    Type: Application
    Filed: February 27, 2001
    Publication date: December 13, 2001
    Inventors: Daniel A. Dickman, Sanjay Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu, William Porter
  • NOVEL FORMULATIONS COMPRISING LIPID-REGULATING AGENTS
    Publication number: 20010006662
    Abstract: The present invention is directed to a solid formulation comprising the lipid-regulating agent dispersed in a hydrophilic, amorphous polymer in which said lipid-regulating agent is present as a meta-stable, amorphous phase.
    Type: Application
    Filed: May 29, 1999
    Publication date: July 5, 2001
    Inventors: STEVEN L. KRILL, ERIC A. SCHMITT, JAMES J. FORT